NCT07004803 Virtual Reality on Pain and Fear Levels of Children With Primary Immunodeficiency
| NCT ID | NCT07004803 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Dr. Hatice Dönmez |
| Condition | Primary Immunodeficiency Diseases (PID) |
| Study Type | INTERVENTIONAL |
| Enrollment | 32 participants |
| Start Date | 2024-09-15 |
| Primary Completion | 2025-09-15 |
Trial Parameters
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
In this study, it is aimed to investigate the effect of virtual reality and tablet video viewing intervention on pain and fear levels and vital signs of children during peripheral venous catheter placement for intravenous immunoglobulin (IVIG) administration.
Eligibility Criteria
Inclusion Criteria: * Being between the ages of 4-11 * Being followed up with the diagnosis of Primary Immunodeficiency for at least 6 months * To accept participation in the study voluntarily * No additional chronic disease other than primary immunodeficiency Exclusion Criteria: * Organ failure is present * Having a mental deficiency * Having a disability to use VR Glasses * Children with fever (\|\>37.5 C0) * Children with severe dehydration